Level Four Advisory Services’s Allena Pharmaceuticals ALNA Stock Holding History

Level Four Advisory Services’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40,000	Closed	-$8K	–	599
2022 Q2	$8K	Hold	40,000	–	–	﹤0.01%	553
2022 Q1	$9K	Hold	40,000	–	–	﹤0.01%	640
2021 Q4	$24K	Buy	+40,000	New	+$31.3K	﹤0.01%	640

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Level Four Advisory Services's ALNA Position: Q3 2022 in Review

Level Four Advisory Services sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 40,000 shares — an estimated $8K sold.

Level Four Advisory Services first reported a position in ALNA in Q4 2021 and held it in 3 quarters. The position peaked at $24K in Q4 2021. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Level Four Advisory Services reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Level Four Advisory Services sold 40,000 Allena Pharmaceuticals shares in Q3 2022, an estimated $8K.
Level Four Advisory Services first reported a position in Allena Pharmaceuticals in Q4 2021 and held it in 3 quarters.
Level Four Advisory Services's Allena Pharmaceuticals position peaked at $24K in Q4 2021.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Level Four Advisory Services's 13F filing for Q3 2022, filed 7 Nov 2022.